Bullish option flow detected in Crispr Therapeutics with 2,450 calls trading, 1.2x expected, and implied vol increasing over 1 point to 51.06%. 6/23 weekly 58 calls and 6/23 weekly 59 calls are the most active options, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.14. Earnings are expected on August 8th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CRSP:
- CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
- CRSP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- CRISPR Therapeutics to Participate Upcoming Investor Conferences
- Crispr Therapeutics options imply 2.4% move in share price post-earnings
- Crispr Therapeutics CEO Kulkarni sells $1.3M in company shares